dc.relation.reference | Aaronson, D. S., and Horvath, C. M. (2002). A road map for those who don't know JAK-STAT. Science 296, 1653-1655.
Alexander, W. S. (2002). Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2, 410-416.
Appleby, M. W., and Ramsdell, F. (2003). A forward-genetic approach for analysis of the immune system. Nat Rev Immunol 3, 463-471.
Bach, E. A., Aguet, M., and Schreiber, R. D. (1997). The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15, 563-591.
Banninger, G., and Reich, N. C. (2004). STAT2 nuclear trafficking. J Biol Chem 279, 39199-39206.
Brierley, M. M., Marchington, K. L., Jurisica, I., and Fish, E. N. (2006). Identification of GAS-dependent interferon-sensitive target genes whose transcription is STAT2-dependent but ISGF3-independent. Febs J 273, 1569-1581.
Burfoot, M. S., Rogers, N. C., Watling, D., Smith, J. M., Pons, S., Paonessaw, G., Pellegrini, S., White, M. F., and Kerr, I. M. (1997). Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J Biol Chem 272, 24183-24190.
Chen, J., Baig, E., and Fish, E. N. (2004). Diversity and relatedness among the type I interferons. J Interferon Cytokine Res 24, 687-698.
Chen, Y., Yee, D., and Magnuson, T. (2006). A novel mouse Smad4 mutation reduces protein stability and wild-type protein levels. Mamm Genome 17, 211-219.
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., and Shuai, K. (1997). Specific inhibition of Stat3 signal transduction by PIAS3. Science 278, 1803-1805.
Darnell, J. E., Jr. (1997). STATs and gene regulation. Science 277, 1630-1635.
Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
David, M., Chen, H. E., Goelz, S., Larner, A. C., and Neel, B. G. (1995). Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 15, 7050-7058.
Decker, T., and Kovarik, P. (2000). Serine phosphorylation of STATs. Oncogene 19, 2628-2637.
Decker, T., Muller, M., and Stockinger, S. (2005). The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 5, 675-687.
Frahm, T., Hauser, H., and Koster, M. (2006). IFN-type-I-mediated signaling is regulated by modulation of STAT2 nuclear export. J Cell Sci 119, 1092-1104.
Gobin, S. J., van Zutphen, M., Woltman, A. M., and van den Elsen, P. J. (1999). Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J Immunol 163, 1428-1434.
Hahm, B., Trifilo, M. J., Zuniga, E. I., and Oldstone, M. B. (2005). Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22, 247-257.
Hilton, D. J. (1999). Negative regulators of cytokine signal transduction. Cell Mol Life Sci 55, 1568-1577.
Hilton, D. J., Richardson, R. T., Alexander, W. S., Viney, E. M., Willson, T. A., Sprigg, N. S., Starr, R., Nicholson, S. E., Metcalf, D., and Nicola, N. A. (1998). Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A 95, 114-119.
Ihle, J. N. (1995). The Janus protein tyrosine kinases in hematopoietic cytokine signaling. Semin Immunol 7, 247-254.
Irie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M., Welstead, G., Griffiths, E., Krawczyk, C., Richardson, C. D., Aitken, K., et al. (2001). CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409, 349-354.
Jun, J. E., Wilson, L. E., Vinuesa, C. G., Lesage, S., Blery, M., Miosge, L. A., Cook, M. C., Kucharska, E. M., Hara, H., Penninger, J. M., et al. (2003). Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18, 751-762.
Justice, M. J., Noveroske, J. K., Weber, J. S., Zheng, B., and Bradley, A. (1999). Mouse ENU mutagenesis. Hum Mol Genet 8, 1955-1963.
Karaghiosoff, M., Steinborn, R., Kovarik, P., Kriegshauser, G., Baccarini, M., Donabauer, B., Reichart, U., Kolbe, T., Bogdan, C., Leanderson, T., et al. (2003). Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 4, 471-477.
Kim, H., Suh, J. M., Hwang, E. S., Kim, D. W., Chung, H. K., Song, J. H., Hwang, J. H., Park, K. C., Ro, H. K., Jo, E. K., et al. (2003). Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling. J Immunol 171, 616-627.
Klingmuller, U., Lorenz, U., Cantley, L. C., Neel, B. G., and Lodish, H. F. (1995). Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80, 729-738.
Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D., and Shuai, K. (1998). Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci U S A 95, 10626-10631.
Mahboubi, K., and Pober, J. S. (2002). Activation of signal transducer and activator of transcription 1 (STAT1) is not sufficient for the induction of STAT1-dependent genes in endothelial cells. Comparison of interferon-gamma and oncostatin M. J Biol Chem 277, 8012-8021.
Morris, A. C., Beresford, G. W., Mooney, M. R., and Boss, J. M. (2002). Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation. Mol Cell Biol 22, 4781-4791.
Navarro, A., Anand-Apte, B., Tanabe, Y., Feldman, G., and Larner, A. C. (2003). A PI-3 kinase-dependent, Stat1-independent signaling pathway regulates interferon-stimulated monocyte adhesion. J Leukoc Biol 73, 540-545.
Neel, B. G. (1993). Structure and function of SH2-domain containing tyrosine phosphatases. Semin Cell Biol 4, 419-432.
Nishio, M., Tsurudome, M., Ito, M., Garcin, D., Kolakofsky, D., and Ito, Y. (2005). Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication. J Virol 79, 8591-8601.
O'Keefe, G. M., Nguyen, V. T., Ping Tang, L. L., and Benveniste, E. N. (2001). IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. J Immunol 166, 2260-2269.
Park, C., Lecomte, M. J., and Schindler, C. (1999). Murine Stat2 is uncharacteristically divergent. Nucleic Acids Res 27, 4191-4199.
Park, C., Li, S., Cha, E., and Schindler, C. (2000). Immune response in Stat2 knockout mice. Immunity 13, 795-804.
Paulus, C., Krauss, S., and Nevels, M. (2006). A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A 103, 3840-3845.
Pestka, S. (1997). The human interferon-alpha species and hybrid proteins. Semin Oncol 24, S9-4-S9-17.
Pestka, S., Kotenko, S. V., Muthukumaran, G., Izotova, L. S., Cook, J. R., and Garotta, G. (1997) The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor.
Pestka, S., Krause, C. D., and Walter, M. R. (2004) Interferons, interferon-like cytokines, and their receptors.
Pestka, S., Langer, J. A., Zoon, K. C., and Samuel, C. E. (1987b). Interferons and their actions. Annu Rev Biochem 56, 727-777.
Platanias, L. C. (2003). The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol Ther 98, 129-142.
Platanias, L. C. (2005). Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5, 375-386.
Platanias, L. C., Uddin, S., Yetter, A., Sun, X. J., and White, M. F. (1996). The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J Biol Chem 271, 278-282.
Quwailid, M. M., Hugill, A., Dear, N., Vizor, L., Wells, S., Horner, E., Fuller, S., Weedon, J., McMath, H., Woodman, P., et al. (2004). A gene-driven ENU-based approach to generating an allelic series in any gene. Mamm Genome 15, 585-591.
Ramaswamy, M., Shi, L., Varga, S. M., Barik, S., Behlke, M. A., and Look, D. C. (2006). Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344, 328-339.
Rogers, R. S., Horvath, C. M., and Matunis, M. J. (2003). SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation. J Biol Chem 278, 30091-30097.
Schindler, C., Shuai, K., Prezioso, V. R., and Darnell, J. E., Jr. (1992). Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809-813.
Shuai, K., Schindler, C., Prezioso, V. R., and Darnell, J. E., Jr. (1992). Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258, 1808-1812.
Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., and Schreiber, R. D. (1998). How cells respond to interferons. Annu Rev Biochem 67, 227-264.
Stockinger, S., Materna, T., Stoiber, D., Bayr, L., Steinborn, R., Kolbe, T., Unger, H., Chakraborty, T., Levy, D. E., Muller, M., and Decker, T. (2002). Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J Immunol 169, 6522-6529.
Stockinger, S., Reutterer, B., Schaljo, B., Schellack, C., Brunner, S., Materna, T., Yamamoto, M., Akira, S., Taniguchi, T., Murray, P. J., et al. (2004). IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J Immunol 173, 7416-7425.
Taniguchi, T., Ogasawara, K., Takaoka, A., and Tanaka, N. (2001). IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19, 623-655.
Taniguchi, T., and Takaoka, A. (2002). The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 14, 111-116.
Uddin, S., Yenush, L., Sun, X. J., Sweet, M. E., White, M. F., and Platanias, L. C. (1995). Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3'-kinase. J Biol Chem 270, 15938-15941.
Ungureanu, D., Vanhatupa, S., Kotaja, N., Yang, J., Aittomaki, S., Janne, O. A., Palvimo, J. J., and Silvennoinen, O. (2003). PIAS proteins promote SUMO-1 conjugation to STAT1. Blood 102, 3311-3313.
You, M., Yu, D. H., and Feng, G. S. (1999). Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 19, 2416-2424.
Yu, P., Constien, R., Dear, N., Katan, M., Hanke, P., Bunney, T. D., Kunder, S., Quintanilla-Martinez, L., Huffstadt, U., Schroder, A., et al. (2005). Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. Immunity 22, 451-465.
Zimmermann, A., Trilling, M., Wagner, M., Wilborn, M., Bubic, I., Jonjic, S., Koszinowski, U., and Hengel, H. (2005). A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med 201, 1543-1553. | en |